La Presse Médicale
Overview
La Presse médicale is a renowned French medical journal that covers a wide range of topics in the field of medicine. With a focus on research, clinical practice, and healthcare policies, it provides valuable insights and updates for healthcare professionals. The journal aims to promote scientific advancements, enhance patient care, and contribute to the overall development of medical knowledge.
Details
Details
Abbr.
Presse Med
Start
1983
End
Continuing
Frequency
Twelve no. a year, 2006?-
p-ISSN
0755-4982
e-ISSN
2213-0276
Country
France
Language
French
Specialty
General Surgery
Metrics
Metrics
h-index / Ranks: 6702
55
SJR / Ranks: 5672
760
CiteScore / Ranks: 11545
1.60
Recent Articles
1.
2.
Ter Haar S, de Jong C, Couturaud F, van Mens T, Klok F
Presse Med
. 2025 Jan;
54(1):104271.
PMID: 39855463
Almost half of the acute pulmonary embolism (PE) survivors suffer from long-term sequelae that limit quality of life and their reintegration in society. The post-PE syndrome involves a spectrum of...
3.
Jaccard A, Pascal V, Magy L, Roussel M
Presse Med
. 2025 Jan;
54(1):104270.
PMID: 39848571
POEMS syndrome (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin changes) is a syndrome that involves a monoclonal B-cell proliferation, most often plasmacytic, and a variable number of manifestations listed or not...
4.
Saade C, Ghobrial I, Ghobrial I
Presse Med
. 2025 Jan;
54(1):104268.
PMID: 39832697
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) are premalignant stages in the development of multiple myeloma (MM). Advances in detection, risk stratification, and therapeutic intervention have...
5.
Shih S, Visram A, Mian H
Presse Med
. 2024 Dec;
54(1):104266.
PMID: 39674493
Multiple myeloma (MM) is an incurable cancer of older adults. Given the aging population, the prevalence of older adults with MM is expected to further increase over the next decade....
6.
Hughes M, Lentzsch S
Presse Med
. 2024 Dec;
54(1):104267.
PMID: 39672504
Primary systemic amyloidosis, or light chain (AL) amyloidosis, is a rare lymphoproliferative disorder in which aberrant light-chain immunoglobulins secreted into the bloodstream aggregate into fibrils and deposit into tissues, causing...
7.
Moukalled N, Malard F, Bazarbachi A, Mohty M
Presse Med
. 2024 Dec;
54(1):104261.
PMID: 39662763
Minimal Residual Disease (MRD) in multiple myeloma has emerged as a significant prognostic factor, guiding treatment strategies and enhancing patient outcomes. Despite advancements in therapies such as proteasome inhibitors, immunomodulatory...
8.
Bridoux F, Leung N, Nasr S, Jaccard A, Royal V
Presse Med
. 2024 Dec;
54(1):104264.
PMID: 39662762
Renal disease is a frequent complication of symptomatic multiple myeloma, that increases morbidity and reduces quality of life and overall survival. It may result from various lesions, the most frequent...
9.
Zhou X, Kortuem K, Rasche L, Einsele H
Presse Med
. 2024 Dec;
54(1):104265.
PMID: 39662761
Although the prognosis of patients with multiple myeloma (MM) has been significantly improved by the introduction of proteasome inhibitors, immunomodulatory drugs and monoclonal antibodies, MM is still considered an incurable...
10.
Virk J, Hillengass J
Presse Med
. 2024 Dec;
54(1):104263.
PMID: 39662760
Multiple myeloma (MM) is the second most common adult hematologic malignancy, characterized by clonal proliferation of malignant plasma cells mostly in the bone marrow. The presence of destructive changes of...